3rd Quarter - Amendment

JEFFREY J. KIMBELL & ASSOCIATES, INC. for ASTELLAS PHARMA US

Firm
Client
Income
$75,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
3rd Quarter - Report Oct 19, 2009 $75,000 Replaced
3rd Quarter - Report Nov 20, 2009 $75,000 Replaced
3rd Quarter - Amendment (this page) Dec 7, 2009 $75,000 Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

REIMBURSEMENT ISSUES

Foreign entity interest: Astellas Pharma, Inc. maintains an interest in all issues identified above.

LobbyistCovered position, as disclosed
JEFFREY J KIMBELL —
JODIE LOCKHART —
JENNIFER VESEY ROSSMAN POLICY ADVISOR, SEN. RICK SANTORUM

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS)

Health Issues HCR

PHARMACEUTICAL AND LIFE SCIENCES ISSUES

Foreign entity interest: Astellas Pharma, Inc. maintains an interest in all issues identified above.

LobbyistCovered position, as disclosed
JEFFREY J KIMBELL —
JODIE LOCKHART —
JENNIFER VESEY ROSSMAN POLICY ADVISOR, SEN. RICK SANTORUM

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
ASTELLAS PHARMA, INC Japan Japan 99.9% —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.